Abstract
Tryptophan hydroxylase 1 (TPH1) has emerged as a target for the treatment of metabolic diseases including obesity and fatty liver disease. A series of xanthine derivatives were synthesized and evaluated for their TPH1 inhibition. Among the synthesized compounds, compound 40 showed good in vitro activity and liver microsomal stability. Docking studies revealed that compound 40 showed better binding to TPH1 via key intermolecular interactions involving the xanthine scaffold, imidazo-thiazolyl ring, and hydroxyl-containing phenacyl moiety. In addition, compound 40 effectively suppressed the adipocyte differentiation of 3 T3-L1 cells.
Original language | English |
---|---|
Article number | 129461 |
Journal | Bioorganic and Medicinal Chemistry Letters |
Volume | 94 |
DOIs | |
State | Published - 1 Oct 2023 |
Keywords
- Fatty liver
- Obesity
- TPH inhibitor
- Xanthine